Tislelizumab Combined With Anlotinib and Chemotherapy (XELOX) in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (TALENT)
PHASE1
This is a Phase 2, multi-cohort study to investigate safety, anti-tumor act...
Status
Completed
Location
The First Affiliated Hospital with Nanjing Medical University
A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer
PHASE3
This is an open label, randomized, phase β ’ study to treat subjects with RAS...
Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes
PHASE1
Abstract Study title: Single-center, Multi-cohort Exploratory Phase Ib/II C...
A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOx
PHASE2
A clinical study to compare the efficacy and safety of AK105 plus anlotinib...